Portage biotech to present at the piper sandler 33rd annual healthcare conference

Westport, conn., nov. 22, 2021 (globe newswire) -- portage biotech inc. (nasdaq: prtg) (“portage” or the “company”), a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, today announced that chief executive officer, dr. ian walters, will participate in the piper sandler 33rd annual virtual healthcare conference being held on november 29-december 2, 2021. dr. walters will give an overview of portage's pipeline and status of current programs, including the company's lead invariant natural killer t cell (inkt) agonists, port-2 and port-3.
ATON Ratings Summary
ATON Quant Ranking